(MENAFNEditorial)
Digestive remedies in Brazil continued to show a healthy performance in 2014 growing by 9% in current value terms to reach BRL2091 million. This performance was aligned with that registered in the review period when the category increased by a CAGR of 10% in current value terms. Low- to middle-income consumers continue to play an important role in this category as they witnessed a strong increase in their disposable incomes in the last decade and consequently increased their access to OTC...
Euromonitor International's Digestive Remedies in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014 allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.
Product Coverage:Diarrhoeal Remedies IBS Treatments Indigestion and Heartburn Remedies Laxatives Motion Sickness Remedies Paediatric Digestive Remedies.
Full Report Details at
- http://www.fastmr.com/prod/1000359_digestive_remedies_brazil.aspx?afid=101
Data Coverage:market sizes (historic and forecasts) company shares brand shares and distribution data.
Reasons to Get this Report
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports business reference books and online information systems. With offices in London Chicago Singapore Shanghai Vilnius Dubai Cape Town Santiago Sydney Tokyo and Bangalore and a network of over 800 analysts worldwide Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Report Table of Contents:
DIGESTIVE REMEDIES IN BRAZIL
Euromonitor International
April 2015
LIST OF CONTENTS AND TABLES
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Digestive Remedies by Category: Value 2009-2014
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2009-2014
Table 3 NBO Company Shares of Digestive Remedies: % Value 2010-2014
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2011-2014
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2014-2019
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2014-2019
Boehringer Ingelheim Do Brasil Quimica E Farmaceutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 1 Boehringer Ingelheim do Brasil Quimica e Farmaceutica Ltda: Key Facts
Company Background
Production
Summary 2 Boehringer Ingelheim do Brasil Quimica e Farmaceutica Ltda: Production Statistics 2014
Competitive Positioning
Summary 3 Boehringer Ingelheim do Brasil Quimica e Farmaceutica Ltda: Competitive Position 2014
Hypermarcas SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 4 Hypermarcas SA: Key Facts
Summary 5 Hypermarcas SA: Operational Indicators
Company Background
Production
Summary 6 Hypermarcas SA: Production Statistics 2014
Competitive Positioning
Summary 7 Hypermarcas SA: Competitive Position 2014
Sanofi-aventis Farmaceutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 8 Sanofi-Aventis Farmaceutica Ltda: Key Facts
Company Background
Production
Summary 9 Sanofi-Aventis Farmaceutica Ltda: Production Statistics 2014
Competitive Positioning
Summary 10 Sanofi-Aventis Farmaceutica Ltda: Competitive Position 2014
Executive Summary
Improper Self-medication Culture Restricts OTC Sales Growth in Brazil
New Anvisa Regulation Allows Interchangeability Between Similar Medications and Generics
Negative Media Hampers the Growth of Local Sports Nutrition Brands
Continued Investment in Private Label by Chemists/pharmacies
Brazil Witnesses A Slowdown in OTC Consumption During the 2014 Fifa World Cup
Key Trends and Developments
Improper Self-medication Culture Restricts OTC Sales Growth in Brazil
New Anvisa Regulation Allows Interchangeability Between Similar Medicines and Generics
Negative Media Hampers the Growth of Local Sports Nutrition Brands
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 8 Life Expectancy at Birth 2009-2014
Market Data
Table 9 Sales of Consumer Health by Category: Value 2009-2014
Table 10 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 11 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 12 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 13 Distribution of Consumer Health by Format: % Value 2009-2014
Table 14 Distribution of Consumer Health by Format and Category: % Value 2014
Table 15 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 11 Research Sources
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts we provide quick and easy access to the best competitive intelligence available. Our unbiased expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.